BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 33274632)

  • 21. Kinetic mechanism of protein arginine methyltransferase 6 (PRMT6).
    Obianyo O; Thompson PR
    J Biol Chem; 2012 Feb; 287(8):6062-71. PubMed ID: 22219200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glutathionylation Decreases Methyltransferase Activity of PRMT5 and Inhibits Cell Proliferation.
    Yi M; Ma Y; Chen Y; Liu C; Wang Q; Deng H
    Mol Cell Proteomics; 2020 Nov; 19(11):1910-1920. PubMed ID: 32868396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of mep50 in adult and embryos of medaka fish (Oryzias latipes).
    Cheng N; Guo M; Chang P; Zhang X; Zhang R; Qi C; Zhong X; Zhou Q; Zhao H
    Fish Physiol Biochem; 2016 Jun; 42(3):1053-61. PubMed ID: 26749004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of Macrocyclic PRMT5-Adaptor Protein Interaction Inhibitors.
    Krzyzanowski A; Esser LM; Willaume A; Prudent R; Peter C; 't Hart P; Waldmann H
    J Med Chem; 2022 Nov; 65(22):15300-15311. PubMed ID: 36378254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PRMT5 (Janus kinase-binding protein 1) catalyzes the formation of symmetric dimethylarginine residues in proteins.
    Branscombe TL; Frankel A; Lee JH; Cook JR; Yang Z; Pestka S; Clarke S
    J Biol Chem; 2001 Aug; 276(35):32971-6. PubMed ID: 11413150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sulforaphane inhibits PRMT5 and MEP50 function to suppress the mesothelioma cancer cell phenotype.
    Ezeka G; Adhikary G; Kandasamy S; Friedberg JS; Eckert RL
    Mol Carcinog; 2021 Jul; 60(7):429-439. PubMed ID: 33872411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Curcumin ameliorates PRMT5-MEP50 arginine methyltransferase expression by decreasing the Sp1 and NF-YA transcription factors in the A549 and MCF-7 cells.
    Chatterjee B; Ghosh K; Suresh L; Kanade SR
    Mol Cell Biochem; 2019 May; 455(1-2):73-90. PubMed ID: 30392062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lead induces the up-regulation of the protein arginine methyltransferase 5 possibly by its promoter demethylation.
    Ghosh K; Chatterjee B; Kanade SR
    Biochem J; 2018 Aug; 475(16):2653-2666. PubMed ID: 30054435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evolutionarily divergent type II protein arginine methyltransferase in Trypanosoma brucei.
    Pasternack DA; Sayegh J; Clarke S; Read LK
    Eukaryot Cell; 2007 Sep; 6(9):1665-81. PubMed ID: 17601874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biochemical Investigation of the Interaction of pICln, RioK1 and COPR5 with the PRMT5-MEP50 Complex.
    Krzyzanowski A; Gasper R; Adihou H; Hart P'; Waldmann H
    Chembiochem; 2021 Jun; 22(11):1908-1914. PubMed ID: 33624332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction assessments of the first S-adenosylmethionine competitive inhibitor and the essential interacting partner methylosome protein 50 with protein arginine methyltransferase 5 by combined computational methods.
    Zhu K; Jiang CS; Hu J; Liu X; Yan X; Tao H; Luo C; Zhang H
    Biochem Biophys Res Commun; 2018 Jan; 495(1):721-727. PubMed ID: 29154828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteomics profiling of arginine methylation defines PRMT5 substrate specificity.
    Musiani D; Bok J; Massignani E; Wu L; Tabaglio T; Ippolito MR; Cuomo A; Ozbek U; Zorgati H; Ghoshdastider U; Robinson RC; Guccione E; Bonaldi T
    Sci Signal; 2019 Apr; 12(575):. PubMed ID: 30940768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PRMT5 confers lipid metabolism reprogramming, tumour growth and metastasis depending on the SIRT7-mediated desuccinylation of PRMT5 K387 in tumours.
    Yuan HF; Zhao M; Zhao LN; Yun HL; Yang G; Geng Y; Wang YF; Zheng W; Yuan Y; Song TQ; Niu JQ; Zhang XD
    Acta Pharmacol Sin; 2022 Sep; 43(9):2373-2385. PubMed ID: 35046516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myc and Omomyc functionally associate with the Protein Arginine Methyltransferase 5 (PRMT5) in glioblastoma cells.
    Mongiardi MP; Savino M; Bartoli L; Beji S; Nanni S; Scagnoli F; Falchetti ML; Favia A; Farsetti A; Levi A; Nasi S; Illi B
    Sci Rep; 2015 Nov; 5():15494. PubMed ID: 26563484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinetic Analysis of PRMT1 Reveals Multifactorial Processivity and a Sequential Ordered Mechanism.
    Brown JI; Koopmans T; van Strien J; Martin NI; Frankel A
    Chembiochem; 2018 Jan; 19(1):85-99. PubMed ID: 29112789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PRMT3 is a distinct member of the protein arginine N-methyltransferase family. Conferral of substrate specificity by a zinc-finger domain.
    Frankel A; Clarke S
    J Biol Chem; 2000 Oct; 275(42):32974-82. PubMed ID: 10931850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein Arginine Methyltransferase 5 (PRMT5) as an Anticancer Target and Its Inhibitor Discovery.
    Wang Y; Hu W; Yuan Y
    J Med Chem; 2018 Nov; 61(21):9429-9441. PubMed ID: 29870258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The N-terminal sequence of murine PRMT5 variant 2 is required for Hsp70 interaction and CHIP ligase-mediated degradation.
    Lu W; Kim JD; Tabara S; Kwon C; Mizukami H; Kimura K; Fukamizu A
    Biochem Biophys Res Commun; 2019 Jul; 514(4):1185-1191. PubMed ID: 31103260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein Arginine Methyltransferase Product Specificity Is Mediated by Distinct Active-site Architectures.
    Jain K; Warmack RA; Debler EW; Hadjikyriacou A; Stavropoulos P; Clarke SG
    J Biol Chem; 2016 Aug; 291(35):18299-308. PubMed ID: 27387499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A glutamate/aspartate switch controls product specificity in a protein arginine methyltransferase.
    Debler EW; Jain K; Warmack RA; Feng Y; Clarke SG; Blobel G; Stavropoulos P
    Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2068-73. PubMed ID: 26858449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.